This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Innovations by Inventor Yuan Tian
Introduction
Yuan Tian is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biochemistry, particularly in the development of substrates for γ-secretase. His work is crucial for advancing research in Alzheimer's disease and related conditions.
Latest Patents
Yuan Tian holds a patent for γ-secretase substrates and methods of use. This patent includes polypeptide substrates based on modifications or fragments of various APP isoforms. The assay methods and screening methods described in the patent are adapted for use in high throughput multi-well plate assay apparatuses. The substrate polypeptides are often labeled for ease of detection and may bind specific ligands that are also labeled. These features enhance the specificity and sensitivity of detection, making the methods particularly suited for high throughput assay formats. Additionally, the patent identifies small polypeptides based on a subsequence motif of Aβ that are potent inhibitors of γ-secretase activity.
Career Highlights
Yuan Tian is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to contribute to innovative research in cancer and neurodegenerative diseases. His work has implications for both therapeutic development and understanding disease mechanisms.
Collaborations
Yuan collaborates with esteemed colleagues, including Christopher Chad Shelton and Yueming Li, to further enhance the impact of his research.
Conclusion
Yuan Tian's innovative work in developing γ-secretase substrates represents a significant advancement in the field of biochemistry. His contributions are vital for ongoing research and potential therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
